C34
Conditions
Interventions
Group 1: control group (usual palliative care)
Group 2: intervention group - telemedically augmented palliative care (telepresence system, database)
Sponsors
Medizinische Universität Wien
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: PATIENTS: • Patients of each sex between 18 and 75 years • Patients with histologically or cytologically confirmed incurable NSCLC, stage IV • Inclusion has to be before the first chemotherapy is received • Patients with an ECOG performance status of 0, 1 or 2 (with 0 indicating that the patient is asymptomatic, 1 that the patient is symptomatic but fully ambulatory, and 2 that the patient is symptomatic and in bed <50 % of the day) • Patients without cognitive impairment FAMILY CAREGIVERS: (for every patient, one of his/her caregivers will be included) • Family caregivers without cognitive impairment
Exclusion criteria
Exclusion criteria: PATIENTS: • All patients without signed informed consent (including persons unable to give consent) • Patients with prior chemotherapy for metastatic disease • Patients with ECOG > 2 • Patients with cognitive impairment FAMILY CAREGIVERS: • Family caregivers without signed informed consent (including persons unable to give consent) • Family caregivers with cognitive impairment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improve patients’ and family caregivers’ quality of life via validated questionnaires (HADS, FAMCARE, EORTC QLQ--C15--PAL) at three different points of time: baseline (recruitment), 10 weeks after baseline, 20 weeks after baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of hospital admissions and emergency room visits during study period (1 year or until death of the patient). | — |
Countries
Austria
Contacts
Public ContactRomina Nemecek
Medizinische Universität Wien
Outcome results
None listed